Skip to main content
Fig. 2 | Radiation Oncology

Fig. 2

From: Effects of EGFR-TKIs combined with intracranial radiotherapy in EGFR-mutant non-small cell lung cancer patients with brain metastases: a retrospective multi-institutional analysis

Fig. 2

Survival outcomes in all patients

Fig. 2A OS for patients treated with upfront TKI vs. upfront TKI + RT; Fig. 2B: iPFS for patients treated with upfront TKI vs. upfront TKI + RT; Fig. 2C: OS for patients treated with upfront TKI vs. upfront TKI + WBRT vs. upfront TKI + SRS/fSRS; Fig. 2D: iPFS for patients treated with upfront TKI vs. upfront TKI + WBRT vs. upfront TKI + SRS/fSRS

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us